The Cross-Sectional Evaluation of the Use of Artemisinin-Based Combination Therapy for Treatment of Malaria Infection at a Tertiary Hospital in Nigeria

Table 2

Prescription pattern of antimalarial drugs .

Antimalarial drug regimens prescribed	(%)
Non-artemisinin monotherapies (NAMTs)	8 (2.4)
Proguanil	5 (1.5)
Sulphadoxine-Pyrimethamine	2 (0.6)
Amodiaquine	1 (0.3)
Artemisinin monotherapies (AMTs)	6 (1.8)
Artesunate	2 (0.6)
Arteether	2 (0.6)
Artemether	1 (0.3)
Dihydroartemisinin	1 (0.3)
Artemisinin combination therapies (ACTs)	319 (95.8)
Artemether/Lumefantrine	269 (80.8)
Artesunate/Mefloquine	20 (6.0)
Dihydroartemisinin/Piperaquine	16 (4.8)
Artesunate/Amodiaquine	8 (2.4)
Artesunate/Piperaquine	4 (1.2)
Artemether/Lumefantrine + Sulphadoxine-Pyrimethamine	1 (0.3)
Artesunate/Sulphadoxine-Pyrimethamine + Proguanil	1 (0.3)